{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:45:07Z","timestamp":1767134707279,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":74,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd007655.pub2","type":"reference-entry","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T14:55:48Z","timestamp":1256136948000},"source":"Crossref","is-referenced-by-count":4,"title":["Blood pressure lowering efficacy of reserpine for primary hypertension"],"prefix":"10.1002","author":[{"given":"Sandy D","family":"Shamon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco I","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10,7]]},"reference":[{"key":"10.1002\/14651858.CD007655.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.0954-6820.1957.tb14448.x","article-title":"Hypotensive effect of reserpine compared with phenobarbital and placebo","volume":"157","author":"Krogsgaard","year":"1957","journal-title":"Acta med. Scand"},{"issue":"21","key":"10.1002\/14651858.CD007655.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM195705232562102","article-title":"Technic of controlled drug assay illustrated by a comparative study of Rauwolfia serpentina, Phenobarbital and placebo in the hypertensive patient","volume":"256","author":"Shapiro","year":"1957","journal-title":"New Engl. J. Med."},{"key":"10.1002\/14651858.CD007655.pub2-BIB3|cit3","doi-asserted-by":"crossref","unstructured":"Veterans Administration Cooperative Group A Double Blind Control Study of Antihypertensive Agents: I. Comparative Effectiveness of Reserpine, Reserpine and Hydralazine, and Three Ganglionic Blocking Agents, Chlorisondamine, Mecamyamine, and Pentolinium Tartrate Arch Intern Med 106 1 81 96","DOI":"10.1001\/archinte.1960.03820010083013"},{"issue":"3","key":"10.1002\/14651858.CD007655.pub2-BIB4|cit4","first-page":"395","article-title":"A randomized double-blind study of furosemide-reserpine in essential hypertension","volume":"18","author":"Velasco","journal-title":"Current therapeutic research"},{"issue":"9","key":"10.1002\/14651858.CD007655.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.1955.02960260011004","article-title":"Hypertension treated with rauwolfia serpentina and with reserpine; controlled study disclosing occasional severe depression","volume":"159","author":"Achor","year":"1955","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD007655.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00000441-195608000-00010","article-title":"Reserpine as an antihypertensive in the outpatient clinic, a double blind study","volume":"232","author":"Bello","year":"1956","journal-title":"Am. J. M. Sc."},{"issue":"3","key":"10.1002\/14651858.CD007655.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/0003-4819-44-3-456","article-title":"Reserpine-hydralazine combination therapy of hypertensive disease, with Hydralazine in doses generally below the toxic range","volume":"44","author":"Lee","year":"1956","journal-title":"Ann. Int. Med."},{"issue":"9","key":"10.1002\/14651858.CD007655.pub2-BIB8|cit8","first-page":"1323","article-title":"A hypotensive action of rauwolfia serpentina and reserpine: A double hidden placebo study of ambulatory patients with hypertension","volume":"6","author":"Palmer","year":"1955","journal-title":"Pract. & Digest. Of Treatm"},{"issue":"2","key":"10.1002\/14651858.CD007655.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/01.CIR.16.2.200","article-title":"Effect of Rauwolfia serpentina and reserpine on the blood pressure in essential hypertension","volume":"16","author":"Sheldon","year":"1957","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD007655.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/000331976001100503","article-title":"A Double Blind Evaluation of the Antihypertensive Effect of Reserpine, Phenobarbital, Hydralazine, Syrosingopine, and Placebo in Ambulatory Subjects","volume":"11","author":"Sosa","journal-title":"Angiology"},{"issue":"5360","key":"10.1002\/14651858.CD007655.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/bmj.2.5360.781","article-title":"Methyldopa and hydrochlorothiazide compared with reserpine and hydrochlorothiazide in hypertension","volume":"2","author":"Agnew","year":"1963","journal-title":"Br Med J"},{"issue":"2","key":"10.1002\/14651858.CD007655.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archinternmed.2007.66","article-title":"Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"168","author":"Wright","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD007655.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic (The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT))","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD007655.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1476-5381.1959.tb00936.x","article-title":"Mechanism of action of reserpine in producing gastric haemorrhage and erosion in the mouse","volume":"14","author":"Blackman","year":"1959","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1002\/14651858.CD007655.pub2-BIB15|cit15","unstructured":"Clinical Pharmacology and Therapeutics Clinical-pharmacologic studies and therapy with anti-hypertensive furosemide-reserpine preparations Medizinische Klinik 66 23 1113 7"},{"key":"10.1002\/14651858.CD007655.pub2-BIB16|cit16","first-page":"348","article-title":"Rauwolfia serpentina in essential hypertension","volume":"86","author":"Chakravarty","year":"1951","journal-title":"Indian Med Gaz"},{"key":"10.1002\/14651858.CD007655.pub2-BIB17|cit17","first-page":"2618","article-title":"Experimental investigation of the mechanism of action of reserpine","volume":"110","author":"Checkman","year":"1972","journal-title":"Bulletin of experimental biology and medicine"},{"issue":"6","key":"10.1002\/14651858.CD007655.pub2-BIB18|cit18","first-page":"773","article-title":"Atenolol, chlorthalidone, and reserpine in mild-moderate hypertension: Double-blind comparison","volume":"7","author":"Divitiis","year":"1981","journal-title":"Drugs Under Experimental & Clinical Research"},{"issue":"6822","key":"10.1002\/14651858.CD007655.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(54)92152-2","article-title":"Hypotensive action of reserpine","volume":"266","author":"Doyle","year":"1954","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD007655.pub2-BIB20|cit20","first-page":"233","article-title":"Comparative efficacy of reserpine and guanethidine in thiazide-treated patients with mild to moderate essential hypertension","volume":"17","author":"Ferguson","year":"1975","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD007655.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.54.1.32","article-title":"Patient acceptance of guanethidine as therapy for mild to moderate","volume":"54","author":"Ferguson","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD007655.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0002-9343(54)90022-4","article-title":"The value of rauwolfia serpentine in the hypertensive patient","volume":"17","author":"Finnerty","year":"1954","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1002\/14651858.CD007655.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.1979.03290320021022","article-title":"Step 2 regimens in hypertension. An assessment","volume":"241","author":"Finnerty","journal-title":"Journal of the American Medical Association"},{"issue":"5-6 Pt 1","key":"10.1002\/14651858.CD007655.pub2-BIB24|cit24","first-page":"357","article-title":"Chlorthalidone plus reserpine versus hydrochlorothiazide plus reserpine in a stepped-care approach to the treatment of essential hypertension","volume":"20","author":"Finnerty","journal-title":"Journal of clinical pharmacology"},{"key":"10.1002\/14651858.CD007655.pub2-BIB25|cit25","first-page":"56p","article-title":"The clinical effectiveness of dihydroergocristine - reserpine clopamide combination in the treatment of hypertension","volume":"17th Scientific","author":"Gaskin","journal-title":"Standing Advisory Committee for Medical Research in the British Caribbean"},{"issue":"9","key":"10.1002\/14651858.CD007655.pub2-BIB26|cit26","first-page":"561","article-title":"Reserpine, hydralazine, hydrochlorothiazide combination(Ser-AP-ES) in essential hypertension","volume":"14","author":"Glazer","journal-title":"Current therapeutic research, clinical and experimental"},{"issue":"5","key":"10.1002\/14651858.CD007655.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/08037059709062086","article-title":"Low-dose reserpine\/thiazide combination in first-line treatment of hypertension: efficacy and safety compared to an ACE inhibitor","volume":"6","author":"Griebenow","journal-title":"Blood pressure"},{"issue":"4","key":"10.1002\/14651858.CD007655.pub2-BIB28|cit28","article-title":"Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension","author":"Heran","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007655.pub2-BIB29|cit29","article-title":"Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension","author":"Heran","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007655.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00000441-195502000-00001","article-title":"Treatment of hypertension with oral reserpine alone and in combination with hydralazine and hexamethonium","volume":"229","author":"Hughes","year":"1955","journal-title":"Am. J. M. Sc"},{"issue":"4","key":"10.1002\/14651858.CD007655.pub2-BIB31|cit31","first-page":"1097","article-title":"Therapeutic Efficacy of Oxprenolol in Essential Hypertension: A Double-Blind Comparison with Reserpine","volume":"6","author":"INAGAKI","year":"1978","journal-title":"Japanese Pharmacology and Therapeutics"},{"issue":"6050","key":"10.1002\/14651858.CD007655.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1136\/bmj.2.6050.1476","article-title":"Mild hypertension: a clinical trial conducted in hospital general practice","volume":"2","author":"Joesbury","journal-title":"British medical journal"},{"issue":"7303","key":"10.1002\/14651858.CD007655.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: Assessing the quality of controlled clinical trials.","volume":"323","author":"J\u00fcni","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD007655.pub2-BIB34|cit34","first-page":"3796","article-title":"Clinical Efficacy of Apllobal for Essential Hypertension: A Multicenter Double-Blind Controlled Comparison with Reserpine","volume":"54","author":"Kanda","year":"1977","journal-title":"The Japanese Journal of Clinical and Experimental Medicine"},{"issue":"8","key":"10.1002\/14651858.CD007655.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/jps.2600600805","article-title":"properties of cryptenamine used with reserpine and methyclothiazide","volume":"60","author":"Kennedy","journal-title":"Journal of pharmaceutical sciences"},{"issue":"27","key":"10.1002\/14651858.CD007655.pub2-BIB36|cit36","first-page":"1198","article-title":"Antihypertensive combination-therapy with inositol nicotinate in essential hypertension","volume":"28","author":"Kramer","journal-title":"Die Medizinische Welt"},{"key":"10.1002\/14651858.CD007655.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.0954-6820.1958.tb01792.x","article-title":"Role of reserpine in essential hypertension when used alone or combined with hydralazine","volume":"162","author":"Krogsgaard","year":"1958","journal-title":"Acta Med Scand"},{"issue":"2","key":"10.1002\/14651858.CD007655.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/01.HYP.29.2.651","article-title":"Different concepts in first-line treatment of essential hypertension. Comparison of a low-dose reserpine-thiazide combination with nitrendipine monotherapy","volume":"29","author":"Kronig","journal-title":"Hypertension"},{"issue":"37-38","key":"10.1002\/14651858.CD007655.pub2-BIB39|cit39","first-page":"930","article-title":"Comparative clinical studies on the effect of hydrazine phthalazine and the rauwolfia alkaloid reserpine on blood pressure","volume":"32","author":"Kuhns","year":"1954","journal-title":"Klinische Wochenschrift"},{"key":"10.1002\/14651858.CD007655.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0021-9681(79)90021-3","article-title":"Methodological variation in case-control studies of reserpine and breast cancer","volume":"32","author":"Labarthe","year":"1979","journal-title":"J Chronic Dis"},{"key":"10.1002\/14651858.CD007655.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomized trials","volume":"326","author":"Law","year":"2003","journal-title":"British Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD007655.pub2-BIB42|cit42","first-page":"1224","article-title":"Antihypertensive effects of clopamide administered alone in combination with pindolol or with reserpine and dihydroergocristine","volume":"46","author":"Leary","year":"1989","journal-title":"B CURR THER RES, CLIN EXP"},{"key":"10.1002\/14651858.CD007655.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM195708012570507","article-title":"Effect of varying doses of reserpine on gastric secretion","volume":"257","author":"Liebowitz","year":"1957","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1002\/14651858.CD007655.pub2-BIB44|cit44","first-page":"344","article-title":"A randomised crossover comparison of reserpine and sustained-release nifedipine in hypertension","volume":"43","author":"Manyemba","journal-title":"The Central African journal of medicine"},{"issue":"21","key":"10.1002\/14651858.CD007655.pub2-BIB45|cit45","first-page":"2303","article-title":"Propranolol in the treatment of essential hypertension\u00a0","volume":"237","author":"Mattes","year":"1977","journal-title":"JAMMEDASSOC"},{"issue":"11","key":"10.1002\/14651858.CD007655.pub2-BIB46|cit46","first-page":"683","article-title":"Blind cross-over study of the hypotensive action of reserpine alone and associated with a diuretic (mebutizide)","volume":"53","author":"Nicaise","journal-title":"Bruxelles medical"},{"issue":"6","key":"10.1002\/14651858.CD007655.pub2-BIB47|cit47","first-page":"844","article-title":"Diltiazem for treatment of essential hypertension: A double-blind controlled study with reserpine","volume":"6","author":"Ogawa","year":"1984","journal-title":"CLIN THER"},{"issue":"214","key":"10.1002\/14651858.CD007655.pub2-BIB48|cit48","first-page":"194","article-title":"Treatment of hypertension with quinethazone alone or in combination with reserpine","volume":"203","author":"Parkes","journal-title":"The Practitioner"},{"issue":"6","key":"10.1002\/14651858.CD007655.pub2-BIB49|cit49","first-page":"965","article-title":"effect of an antihypertensive drug during psychological stress. A double-blind study","volume":"25","author":"Rosler","journal-title":"Arzneimittel-Forschung"},{"key":"10.1002\/14651858.CD007655.pub2-BIB50|cit50","first-page":"Supplement 93s-","article-title":"Anti-hypertensive adrenergic-blocking agents: effects on sodium balance, the renin-angiotensin system and haemodynamics","volume":"2","author":"Safar","journal-title":"Clinical science and molecular medicine"},{"issue":"6","key":"10.1002\/14651858.CD007655.pub2-BIB51|cit51","first-page":"433","article-title":"Double-blind comparison of dihydralazine and prazosin in hypertensive patients on the diuretic-reserpine regimen","volume":"13","author":".Salmela","journal-title":"H Annals of clinical research"},{"issue":"34","key":"10.1002\/14651858.CD007655.pub2-BIB52|cit52","first-page":"849","article-title":"Combined uni- and multicenter double-blind studies in hypertensive patients. Comparison of blood pressure measurements","volume":"80","author":"Schmidt","journal-title":"Schweizerische Rundschau fur Medizin Praxis"},{"issue":"23","key":"10.1002\/14651858.CD007655.pub2-BIB53|cit53","first-page":"915","article-title":"Reserpine plus hydrochlorothiazide and sotalol plus hydrochlorothiazide in Black and Indian hypertensivepatients","volume":"65","author":"Seedat","journal-title":"South African medical journal"},{"issue":"5-6","key":"10.1002\/14651858.CD007655.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3109\/10641968909035386","article-title":"The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension","volume":"11","author":"Probstfield","year":"1989","journal-title":"Clinical and experimental hypertension.Part A, Theory and practice"},{"key":"10.1002\/14651858.CD007655.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the ElderlyProgram (SHEP)","volume":"265","year":"1991","journal-title":"JAMA"},{"issue":"12 Pt 1","key":"10.1002\/14651858.CD007655.pub2-BIB56|cit56","first-page":"1147","article-title":"Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP)","volume":"8","author":"Kostis","journal-title":"American journal of hypertension : journal of the American Society of Hypertension"},{"issue":"23","key":"10.1002\/14651858.CD007655.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1001\/jama.1996.03540230036032","article-title":"Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension","volume":"276","author":"Curb","journal-title":"Journal of the American Medical Association"},{"issue":"7","key":"10.1002\/14651858.CD007655.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/01.STR.29.7.1333","article-title":"Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group","volume":"29","author":"Davis","year":"1998","journal-title":"Stroke; a journal of cerebral circulation"},{"issue":"12","key":"10.1002\/14651858.CD007655.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/archinte.158.12.1340","article-title":"Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program","volume":"158","author":"Pahor","journal-title":"Archives of internal medicine"},{"issue":"7","key":"10.1002\/14651858.CD007655.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archinte.158.7.741","article-title":"Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program","volume":"158","author":"Savage","journal-title":"Archives of internal medicine"},{"issue":"4","key":"10.1002\/14651858.CD007655.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/STROKEAHA.107.500777","article-title":"Long-term fatal outcomes in subjects with stroke or transient ischemic attack: Fourteen-year follow-up of the systolic hypertension in the elderly program","volume":"39","author":"Patel","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD007655.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/cpt1969103338","article-title":"Comparative evaluation of Rauwolfia whole root and reserpine","volume":"10","author":"Smith","journal-title":"Clinical pharmacology and therapeutics"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD007655.pub2-BIB63|cit63","first-page":"I98","article-title":"Treatment of mild hypertension: results of a ten-year intervention trial","volume":"40","author":"Smith","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD007655.pub2-BIB64|cit64","first-page":"243","article-title":"Combination of a thiazide, a vasodilator and reserpine compared with methyldopa plus hydrochlorothiazide in the treatment of hypertension in Zimbabwe","volume":"77","author":"Stein","journal-title":"South African medical journal"},{"issue":"3","key":"10.1002\/14651858.CD007655.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/000331975500600308","article-title":"Treatment of hypertension with reserpine (serpasil) alone and in combination with hydralazine (Apresoline)","volume":"6","author":"Stuppy","year":"1955","journal-title":"Angiology"},{"issue":"2","key":"10.1002\/14651858.CD007655.pub2-BIB66|cit66","first-page":"126","article-title":"Circulatory and diuretic effects of hydrochlorothiazide and reserpine in man","volume":"1","author":"Torsti","journal-title":"Annals of clinical research"},{"key":"10.1002\/14651858.CD007655.pub2-BIB67|cit67","first-page":"267","article-title":"Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Plan and preliminary results of a two-year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hypertension","volume":"304","author":"Lung","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD007655.pub2-BIB68|cit68","doi-asserted-by":"crossref","unstructured":"Veterans Administration Cooperative Study Participants Low doses v standard dose of reserpine. A randomized, double-blind, multiclinic trial in patients taking chlorthalidone Journal of the American Medical Association 248 19 2471 7","DOI":"10.1001\/jama.248.19.2471"},{"issue":"4","key":"10.1002\/14651858.CD007655.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.HYP.15.4.348","article-title":"Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative Study","volume":"15","author":"Materson","journal-title":"Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD007655.pub2-BIB70|cit70","first-page":"266","article-title":"Antihypertensive efficacy of metolazone (Zaroxolyn) alone and combined with reserpine in treatment of essential hypertension","volume":"20","author":"Hoose","journal-title":"Current therapeutic research, clinical and experimental"},{"issue":"8","key":"10.1002\/14651858.CD007655.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJM195301082480202","article-title":"The use of rauwolfia serpentina in hypertensive patients","volume":"248","author":"Wilkins","year":"1953","journal-title":"New Engl. J. Med"},{"issue":"3","key":"10.1002\/14651858.CD007655.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0021-9681(66)90128-7","article-title":"Effects of treatment in hypertension. Results of a controlled study","volume":"19","author":"Wolff","journal-title":"Journal of chronic diseases"},{"key":"10.1002\/14651858.CD007655.pub2-BIB73|cit73","first-page":"25","article-title":"Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?","volume":"161","author":"Wright","year":"1999","journal-title":"Candian Medical Journal Association"},{"issue":"3","key":"10.1002\/14651858.CD007655.pub2-BIB74|cit74","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008161","article-title":"First-line drugs for hypertension","author":"Wright","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007655.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T00:00:00Z","timestamp":1482278400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007655.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:12:27Z","timestamp":1628532747000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007655.pub2"}},"subtitle":[],"editor":[{"given":"Sandy D","family":"Shamon","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,7]]},"references-count":74,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007655.pub2","relation":{},"subject":[],"published":{"date-parts":[[2009,10,7]]}}}